Problem 6 - Clinical Chemistry

Question

Porphyria cutanea tarda (PCT) is identified by a. Chromatographic analysis of a 24-h urine collection b. Scanning fluorescence of plasma c. Screening for PBG in a random urine specimen d. Separation of fecal porphyrins in a 24-h specimen

Step-by-Step Solution

Answer

b. Scanning fluorescence of plasma

Step 1: Identify the key task

The task is to identify which method is used to identify Porphyria cutanea tarda (PCT).

Step 2: Analyze option a

Chromatographic analysis of a 24-h urine collection is not typically used for identifying PCT; it is more common for other types of porphyria.

Step 3: Analyze option b

Scanning fluorescence of plasma is the primary method used to identify PCT. This method detects elevated levels of uroporphyrinogen in the plasma.

Step 4: Analyze option c

Screening for PBG (porphobilinogen) in a random urine specimen is used for acute porphyrias, not for PCT.

Step 5: Analyze option d

Separation of fecal porphyrins in a 24-h specimen is not a standard diagnostic method for PCT.

Step 6: Conclusion

The correct method for identifying Porphyria cutanea tarda (PCT) is option b, scanning fluorescence of plasma.

Key Concepts

chromatographic analysis

Chromatographic analysis is a laboratory technique used to separate mixtures into their individual components. This method helps in identifying and quantifying the various substances present in a sample. Chromatographic analysis involves:

• Sample preparation
• Sample injection into the chromatograph
• Separation of components as they pass through the chromatographic medium
• Detection and measurement of the separated components

While chromatographic analysis is valuable for diagnosing various types of porphyria, it is not the primary method for identifying Porphyria cutanea tarda (PCT). It's more commonly used in diagnosing other kinds of porphyria such as acute intermittent porphyria (AIP).

scanning fluorescence

Scanning fluorescence is a diagnostic technique used to detect certain conditions by measuring the fluorescence emitted by specific substances in biological samples like plasma. This method is particularly useful for identifying Porphyria cutanea tarda (PCT). The process usually involves:

• Collection of plasma sample
• Exposure of the sample to a specific wavelength of light
• Detection of the emitted fluorescence
• Analysis of fluorescence patterns to identify elevated uroporphyrinogen levels

By detecting the fluorescence emitted by uroporphyrinogen, scanning fluorescence can effectively diagnose PCT, making it the primary method for this purpose.

uroporphyrinogen detection

Uroporphyrinogen detection plays a crucial role in diagnosing Porphyria cutanea tarda (PCT). Uroporphyrinogen is a precursor in the heme synthesis pathway, and its accumulation in biological fluids is indicative of PCT. Methods used for uroporphyrinogen detection include:

• Chromatographic techniques
• Scanning fluorescence
• Other spectroscopic methods

In the case of PCT, scanning fluorescence is particularly effective because it can specifically identify elevated levels of uroporphyrinogen in the plasma. Detecting uroporphyrinogen elevation helps healthcare professionals confirm the diagnosis of PCT.

PBG screening

PBG screening involves testing urine samples for porphobilinogen (PBG), a compound that builds up in the body during certain types of porphyria. The screening process typically includes:

• Collection of a random urine specimen
• Application of chemical reagents to the sample
• Observation of the color change or fluorescence
• Quantification of PBG levels

PBG screening is commonly used to diagnose acute porphyrias such as acute intermittent porphyria (AIP). However, it is not the preferred method for identifying Porphyria cutanea tarda (PCT). For PCT, scanning fluorescence of plasma is the more accurate diagnostic approach.